DES And Breast Cancer

According to a new study, DES, the anti-miscarriage drug used in the USA but also used in Australia and many European countries decades ago, has been linked to health problems — including breast cancer, infertility, difficult pregnancies and early menopause — in the daughters and the granddaughters of women who took it. The study suggests that one in 50 DES daughters had the chance of developing breast cancer due to their prenatal exposure to DES.